Anne Jörns Clinical Biochemistry Hannover Medical School Biography Publications Institution JoVE Articles Anne Jörns has not added a biography. If you are Anne Jörns and would like to personalize this page please email our Author Liaison for assistance. Publications 生物膜感染风险和促进优化表面钛植入物的骨质减少。 Advanced Healthcare Materials. Jan, 2012 | Pubmed ID: 23184696 耐药性的霍乱弧菌 O1 隔离期间在科特迪瓦旱季 2011年流行霍乱。 Journal of Infection in Developing Countries. 2012 | Pubmed ID: 22842949 关于对增长和生产的人类肿瘤坏死因子-α 链霉菌 Lividans 磷酸烯羧激酶表达的影响。 Applied Microbiology and Biotechnology. Oct, 2012 | Pubmed ID: 22797598 癌症治疗梭菌孢子: 针对实体肿瘤的微环境。 Journal of Toxicology. 2012 | Pubmed ID: 22737166 核糖体失活蛋白的细菌裂缝和其潜在的医学应用为重点。 Future Microbiology. Jun, 2012 | Pubmed ID: 22702525 基因组规模日益复杂的介质上的链霉菌 Lividans 代谢通量分析。 Journal of Biotechnology. Sep, 2012 | Pubmed ID: 22641041 重组蛋白生产和莠。 Journal of Biotechnology. Apr, 2012 | Pubmed ID: 21777629 我信号 Peptidases 作为抗生素目标细菌的类型。 Future Microbiology. Nov, 2011 | Pubmed ID: 22082289 氯己定防腐从微孔非晶态硅在种植体表面开放孔隙中的应用的控制的释放。 International Journal of Pharmaceutics. Oct, 2011 | Pubmed ID: 21798323 交通堵塞在细菌秒 Translocase: 针对赛康纳米马达小分子抑制剂。 Chemistry & Biology. Jun, 2011 | Pubmed ID: 21700205 发现小分子赛康抑制剂的高通量筛选检测方法的发展。 Analytical Biochemistry. Jun, 2011 | Pubmed ID: 21338570 2-(1,2-Dihydro-3-oxo-3H-pyrazol-2-yl)benzothiazoles 一种新型系列的合成及抗菌评价。 Chemistry & Biodiversity. Feb, 2011 | Pubmed ID: 21337499 根治术后的疟原虫间日疟 Sub-patent 感染常见于秘鲁病人: 1 年前瞻性队列研究的结果。 PloS One. 2011 | Pubmed ID: 21297986 大肠杆菌和 S.金黄色赛康抑制剂作为新型 5-氨基-thiazolo [4,5-d] 嘧啶的合成。 Bioorganic & Medicinal Chemistry. Jan, 2011 | Pubmed ID: 21094610 氨基酸吸收的野生型和重组链霉菌 Lividans TK24 批处理酵的分析。 Journal of Biotechnology. Apr, 2011 | Pubmed ID: 20797416 靶向和锚定杆血浆的果蝇卵母细胞中的都铎王朝。 PloS One. 2010 | Pubmed ID: 21179512 都铎王朝的 C 终端结构包含在果蝇体内的活动。 PloS One. 2010 | Pubmed ID: 21179416 风波之间贴有标签的白血细胞放射性核素显像和骨扫描后怀疑骨感染: 应该做些什么? Nuclear Medicine Review. Central & Eastern Europe. 2010 | Pubmed ID: 21154309 对于革兰阳性的主机,链霉菌 Lividans 的克隆和表达载体。 Methods in Molecular Biology (Clifton, N.J.). 2010 | Pubmed ID: 20830558 精氨酸甲基化 SmB 是果蝇生殖细胞发展需要。 Development (Cambridge, England). Sep, 2010 | Pubmed ID: 20659974 从手术标本的人类胰岛细胞激光显微切割的改进方法 Dorothée Sturm1,2, Lorella Marselli3, Florian Ehehalt1,2, Daniela Richter1, Marius Distler2, Stephan Kersting1,2, Robert Grützmann2, Krister Bokvist4, Philippe Froguel5, Robin Liechti6, Anne Jörns7, Paolo Meda8, Gustavo Bruno Baretton9, Hans-Detlev Saeger2, Anke M. Schulte10, Piero Marchetti3, Michele Solimena1 1Molecular Diabetology, Paul Langerhans Institute Dresden, 2Department of GI-, Thoracic- and Vascular Surgery, University Hospital Carl Gustav Carus, University of Technology Dresden, 3Department of Endocrinology and Metabolism, Metabolic Unit University of Pisa, 4Labs DC0522, Lilly Corporate Center, 5Genomics, Faculty of Medicine Imperial College London, 6Vital-IT, SIB Swiss Institute of Bioinformatics, 7Clinical Biochemistry, Hannover Medical School, 8Cell Physiology and Metabolism, Medical School, University of Geneva, 9Department of Pathology, University Hospital Carl Gustav Carus, University of Technology Dresden, 10R&D DIAB Division / Translational Medicine, Sanofi-Aventis JoVE 50231 Medicine
从手术标本的人类胰岛细胞激光显微切割的改进方法 Dorothée Sturm1,2, Lorella Marselli3, Florian Ehehalt1,2, Daniela Richter1, Marius Distler2, Stephan Kersting1,2, Robert Grützmann2, Krister Bokvist4, Philippe Froguel5, Robin Liechti6, Anne Jörns7, Paolo Meda8, Gustavo Bruno Baretton9, Hans-Detlev Saeger2, Anke M. Schulte10, Piero Marchetti3, Michele Solimena1 1Molecular Diabetology, Paul Langerhans Institute Dresden, 2Department of GI-, Thoracic- and Vascular Surgery, University Hospital Carl Gustav Carus, University of Technology Dresden, 3Department of Endocrinology and Metabolism, Metabolic Unit University of Pisa, 4Labs DC0522, Lilly Corporate Center, 5Genomics, Faculty of Medicine Imperial College London, 6Vital-IT, SIB Swiss Institute of Bioinformatics, 7Clinical Biochemistry, Hannover Medical School, 8Cell Physiology and Metabolism, Medical School, University of Geneva, 9Department of Pathology, University Hospital Carl Gustav Carus, University of Technology Dresden, 10R&D DIAB Division / Translational Medicine, Sanofi-Aventis JoVE 50231 Medicine